Meeting NewsVideo

VIDEO: Eyenovia progressing in mydriasis, glaucoma, myopia treatments

SAN DIEGO At the Ophthalmology Innovation Summit, Sean Ianchulev, MD, MPH, CEO of Eyenovia, discusses the company’s technology in development for mydriasis, as well as glaucoma and myopia treatments.

SAN DIEGO At the Ophthalmology Innovation Summit, Sean Ianchulev, MD, MPH, CEO of Eyenovia, discusses the company’s technology in development for mydriasis, as well as glaucoma and myopia treatments.

    See more from American Society of Cataract and Refractive Surgery